Hypertension Drug Market Report

China Hypertension Drug Industry Market Research Report 2023-2029

  • POSTDATE：Aug 21, 2023
  • PAGES：209
  • REPORT CODE：GMM1748208
  • REPORT SUMMARY
  • TABLE OF CONTENTS

  • This report elaborates on the current development of the Hypertension Drug industry thoroughly based on the international market dynamics and China's market situation.

    For a start, the report provides an in-depth analysis of the current market situation through three different aspects - by region, by type and by application, which includes market distribution of different types and applications, import and export analysis of major regions, development trends of different types of products in each region, market opportunities and market restrains of different applications.

    Secondly, this report lists the major players in the industry, displaying their market positions and strengths and weaknesses of their products, picturing the current competitive situation of the whole market. 

    Last but not least, the report analyzes and predicts the investment prospects and risks in the industry on the basis of industry data, combined with experts' opinions and suggestions.

    By Player:

    • Merck & Co

    • AstraZeneca Plc

    • Pfizer Inc

    • Novartis AG

    • Lupin Limited

    • Sanofi SA

    • Boehringer Ingelheim

    • Daiichi - Sankyo

    • Johnson & Johnson Ltd

    By Type:

    • Calcium Channel Blockers

    • Alpha Blockers

    • Diuretics

    • Renin Inhibitors

    • Angiotensin Receptor Blockers

    • Beta Blockers Vasodilators

    • Angiotensin Converting Enzyme Inhibitors

    By Application:

    • Others

    • Hospital

    • Private Clinic

    By Research Region:

    • North China

    • Central China

    • South China

    • East China

    • Northeast China

    • Southwest China

    • Northwest China

  • TABLE OF CONTENT

    Chapter 1 China Hypertension Drug Market Overview 2018-2029

    • 1.1 China Hypertension Drug Industry Development Overview

    • 1.2 China Hypertension Drug Industry Development History

    • 1.3 China Hypertension Drug Industry Market Size (2018-2029)

    • 1.4 China Hypertension Drug Market Analysis by Type from Production Side

      • 1.4.1 China Hypertension Drug Production Volume, Production Value and Growth Rate of Calcium Channel Blockers (2018-2029)

      • 1.4.2 China Hypertension Drug Production Volume, Production Value and Growth Rate of Alpha Blockers (2018-2029)

      • 1.4.3 China Hypertension Drug Production Volume, Production Value and Growth Rate of Diuretics (2018-2029)

      • 1.4.4 China Hypertension Drug Production Volume, Production Value and Growth Rate of Renin Inhibitors (2018-2029)

      • 1.4.5 China Hypertension Drug Production Volume, Production Value and Growth Rate of Angiotensin Receptor Blockers (2018-2029)

      • 1.4.6 China Hypertension Drug Production Volume, Production Value and Growth Rate of Beta Blockers Vasodilators (2018-2029)

      • 1.4.7 China Hypertension Drug Production Volume, Production Value and Growth Rate of Angiotensin Converting Enzyme Inhibitors (2018-2029)

    • 1.5 China Hypertension Drug Market Analysis by Application from Consumption End

      • 1.5.1 China Hypertension Drug Sales Volume, Sales Value and Growth Rate of Others (2018-2029)

      • 1.5.2 China Hypertension Drug Sales Volume, Sales Value and Growth Rate of Hospital (2018-2029)

      • 1.5.3 China Hypertension Drug Sales Volume, Sales Value and Growth Rate of Private Clinic (2018-2029)

    • 1.6 China Hypertension Drug Market Analysis by Region

      • 1.6.1 North China Hypertension Drug Market Size and Growth Rate from 2018-2029

      • 1.6.2 Central China Hypertension Drug Market Size and Growth Rate from 2018-2029

      • 1.6.3 South China Hypertension Drug Market Size and Growth Rate from 2018-2029

      • 1.6.4 East China Hypertension Drug Market Size and Growth Rate from 2018-2029

      • 1.6.5 Northeast China Hypertension Drug Market Size and Growth Rate from 2018-2029

      • 1.6.6 Southwest China Hypertension Drug Market Size and Growth Rate from 2018-2029

      • 1.6.7 Northwest China Hypertension Drug Market Size and Growth Rate from 2018-2029

    Chapter 2 China Hypertension Drug Industry Development Environment

    • 2.1 Industry Development Environment Analysis

      • 2.1.1 Industry Technological Progress Analysis

      • 2.1.2 Industrial Organizational Innovation Analysis

      • 2.1.3 Changes in Social Habits

      • 2.1.4 Alterations in Government Policies

      • 2.1.5 Impact of Economic Globalization

    • 2.2 Domestic and Foreign Industry Competition Analysis

      • 2.2.1 Comparative Analysis on Hypertension Drug Market Status and Competition at home and abroad in 2023

      • 2.2.2 China Hypertension Drug Market Status and Competition Analysis in 2023

      • 2.2.3 China Hypertension Drug Market Concentration Analysis in 2023

    • 2.3 Problems and Countermeasures in the development of China Hypertension Drug Industry

      • 2.3.1 Industry Development Constraints

      • 2.3.2 Industry Development Considerations

      • 2.3.3 Suggestions on Industry Development Measures

      • 2.3.4 Development Strategies for SMEs

    • 2.4 Influence of COVID-19 Outbreak on Hypertension Drug Industry Development

    Chapter 3 Hypertension DrugIndustry Chain Analysis

    • 3.1 Hypertension Drug Industry Chain

    • 3.2 Hypertension Drug Upstream Industry Analysis

      • 3.2.1 Upstream Industry Development Status

      • 3.2.2 Upstream Industry Development Forecast

      • 3.2.3 Impact of Upstream Industry on the Hypertension Drug Market

    • 3.3 Hypertension Drug Downstream Industry Analysis

      • 3.3.1 Downstream Industry Development Status

      • 3.3.2 Downstream Industry Development Forecast

      • 3.3.3 Impact of Downstream Industry on the Hypertension Drug Market

    Chapter 4 China Hypertension Drug Market, by Type

    • 4.1 China Hypertension Drug Market Trend, by Type

    • 4.2 Product Types of Major Suppliers

    • 4.3 Competitive Landscape of Major Types

    • 4.4 China Hypertension Drug Total Production Volume and Growth Rate from Production Side

    • 4.5 China Hypertension Drug Production Volume and Growth Rate, by Type

      • 4.5.1 China Hypertension Drug Production Volume and Growth Rate of Calcium Channel Blockers

      • 4.5.2 China Hypertension Drug Production Volume and Growth Rate of Alpha Blockers

      • 4.5.3 China Hypertension Drug Production Volume and Growth Rate of Diuretics

      • 4.5.4 China Hypertension Drug Production Volume and Growth Rate of Renin Inhibitors

      • 4.5.5 China Hypertension Drug Production Volume and Growth Rate of Angiotensin Receptor Blockers

      • 4.5.6 China Hypertension Drug Production Volume and Growth Rate of Beta Blockers Vasodilators

      • 4.5.7 China Hypertension Drug Production Volume and Growth Rate of Angiotensin Converting Enzyme Inhibitors

    Chapter 5 China Hypertension Drug Market, by Application

    • 5.1 Downstream Market Overview

    • 5.2 Competitive Landscape of Major Applications

    • 5.3 Market Potential Analysis, by Application

    • 5.4 China Hypertension Drug Total Market Size and Growth Rate from Consumption End

    • 5.5 China Hypertension Drug Market Size and Growth Rate, by Application

      • 5.5.1 China Hypertension Drug Market Size and Growth Rate of Others

      • 5.5.2 China Hypertension Drug Market Size and Growth Rate of Hospital

      • 5.5.3 China Hypertension Drug Market Size and Growth Rate of Private Clinic

    Chapter 6 China Hypertension Drug Market, by Region

    • 6.1 China Hypertension Drug Production Volume and Production Value, by Region

    • 6.2 China Hypertension Drug Sales Volume and Sales Value, by Region

    Chapter 7 North China Hypertension Drug Market Analysis

    • 7.1 North China Hypertension Drug Market, by Type

    • 7.2 North China Hypertension Drug Market, by Application

    Chapter 8 Central China Hypertension Drug Market Analysis

    • 8.1 Central China Hypertension Drug Market, by Type

    • 8.2 Central China Hypertension Drug Market, by Application

    Chapter 9 South China Hypertension Drug Market Analysis

    • 9.1 South China Hypertension Drug Market, by Type

    • 9.2 South China Hypertension Drug Market, by Application

    Chapter 10 East China Hypertension Drug Market Analysis

    • 10.1 East China Hypertension Drug Market, by Type

    • 10.2 East China Hypertension Drug Market, by Application

    Chapter 11 Northeast China Hypertension Drug Market Analysis

    • 11.1 Northeast China Hypertension Drug Market, by Type

    • 11.2 Northeast China Hypertension Drug Market, by Application

    Chapter 12 Southwest China Hypertension Drug Market Analysis

    • 12.1 Southwest China Hypertension Drug Market, by Type

    • 12.2 Southwest China Hypertension Drug Market, by Application

    Chapter 13 Northwest China Hypertension Drug Market Analysis

    • 13.1 Northwest China Hypertension Drug Market, by Type

    • 13.2 Northwest China Hypertension Drug Market, by Application

    Chapter 14 Company Profiles

      • 14.1 Merck & Co

        • 14.1.1 Merck & Co Company Profile

        • 14.1.2 Merck & Co Hypertension Drug Market Performance

        • 14.1.3 Product&Service Introduction

      • 14.2 AstraZeneca Plc

        • 14.2.1 AstraZeneca Plc Company Profile

        • 14.2.2 AstraZeneca Plc Hypertension Drug Market Performance

        • 14.2.3 Product&Service Introduction

      • 14.3 Pfizer Inc

        • 14.3.1 Pfizer Inc Company Profile

        • 14.3.2 Pfizer Inc Hypertension Drug Market Performance

        • 14.3.3 Product&Service Introduction

      • 14.4 Novartis AG

        • 14.4.1 Novartis AG Company Profile

        • 14.4.2 Novartis AG Hypertension Drug Market Performance

        • 14.4.3 Product&Service Introduction

      • 14.5 Lupin Limited

        • 14.5.1 Lupin Limited Company Profile

        • 14.5.2 Lupin Limited Hypertension Drug Market Performance

        • 14.5.3 Product&Service Introduction

      • 14.6 Sanofi SA

        • 14.6.1 Sanofi SA Company Profile

        • 14.6.2 Sanofi SA Hypertension Drug Market Performance

        • 14.6.3 Product&Service Introduction

      • 14.7 Boehringer Ingelheim

        • 14.7.1 Boehringer Ingelheim Company Profile

        • 14.7.2 Boehringer Ingelheim Hypertension Drug Market Performance

        • 14.7.3 Product&Service Introduction

      • 14.8 Daiichi - Sankyo

        • 14.8.1 Daiichi - Sankyo Company Profile

        • 14.8.2 Daiichi - Sankyo Hypertension Drug Market Performance

        • 14.8.3 Product&Service Introduction

      • 14.9 Johnson & Johnson Ltd

        • 14.9.1 Johnson & Johnson Ltd Company Profile

        • 14.9.2 Johnson & Johnson Ltd Hypertension Drug Market Performance

        • 14.9.3 Product&Service Introduction

    Chapter 15 Research Conclusions and Investment Suggestions

    • 15.1 Hypertension Drug Industry Research Conclusions

    • 15.2 Hypertension Drug Industry Investment Suggestions

      • 15.2.1 Suggestions on Industry Development Strategy

      • 15.2.2 Suggestions on Industry Investment Direction

      • 15.2.3 Suggestions on Industry Investment Strategy


    List of Tables and Figures

    • Figure China Hypertension Drug Industry Market Size (2018-2029)

    • Figure China Hypertension Drug Production Volume, Production Value and Growth Rate of Calcium Channel Blockers (2018-2029)

    • Figure China Hypertension Drug Production Volume, Production Value and Growth Rate of Alpha Blockers (2018-2029)

    • Figure China Hypertension Drug Production Volume, Production Value and Growth Rate of Diuretics (2018-2029)

    • Figure China Hypertension Drug Production Volume, Production Value and Growth Rate of Renin Inhibitors (2018-2029)

    • Figure China Hypertension Drug Production Volume, Production Value and Growth Rate of Angiotensin Receptor Blockers (2018-2029)

    • Figure China Hypertension Drug Production Volume, Production Value and Growth Rate of Beta Blockers Vasodilators (2018-2029)

    • Figure China Hypertension Drug Production Volume, Production Value and Growth Rate of Angiotensin Converting Enzyme Inhibitors (2018-2029)

    • Figure China Hypertension Drug Sales Volume, Sales Value and Growth Rate of Others (2018-2029)

    • Figure China Hypertension Drug Sales Volume, Sales Value and Growth Rate of Hospital (2018-2029)

    • Figure China Hypertension Drug Sales Volume, Sales Value and Growth Rate of Private Clinic (2018-2029)

    • Figure North China Hypertension Drug Market Size and Growth Rate from 2018-2029

    • Figure Central China Hypertension Drug Market Size and Growth Rate from 2018-2029

    • Figure South China Hypertension Drug Market Size and Growth Rate from 2018-2029

    • Figure East China Hypertension Drug Market Size and Growth Rate from 2018-2029

    • Figure Northeast China Hypertension Drug Market Size and Growth Rate from 2018-2029

    • Figure Southwest China Hypertension Drug Market Size and Growth Rate from 2018-2029

    • Figure Northwest China Hypertension Drug Market Size and Growth Rate from 2018-2029

    • Figure Hypertension Drug Industry Chain

    • Table Product Types of Major Suppliers in 2023

    • Figure China Hypertension Drug Market Share by Type in 2018

    • Figure China Hypertension Drug Market Share by Type in 2023

    • Figure China Hypertension Drug Total Production Volume and Growth Rate from Production Side (2018-2023)

    • Figure China Hypertension Drug Production Volume and Growth Rate of Calcium Channel Blockers (2018-2023)

    • Figure China Hypertension Drug Production Volume and Growth Rate of Alpha Blockers (2018-2023)

    • Figure China Hypertension Drug Production Volume and Growth Rate of Diuretics (2018-2023)

    • Figure China Hypertension Drug Production Volume and Growth Rate of Renin Inhibitors (2018-2023)

    • Figure China Hypertension Drug Production Volume and Growth Rate of Angiotensin Receptor Blockers (2018-2023)

    • Figure China Hypertension Drug Production Volume and Growth Rate of Beta Blockers Vasodilators (2018-2023)

    • Figure China Hypertension Drug Production Volume and Growth Rate of Angiotensin Converting Enzyme Inhibitors (2018-2023)

    • Figure China Hypertension Drug Market Share by Application in 2018

    • Figure China Hypertension Drug Market Share by Application in 2023

    • Figure China Hypertension Drug Total Market Size and Growth Rate from Consumption End

    • Figure China Hypertension Drug Market Size and Growth Rate of Others (2018-2023)

    • Figure China Hypertension Drug Market Size and Growth Rate of Hospital (2018-2023)

    • Figure China Hypertension Drug Market Size and Growth Rate of Private Clinic (2018-2023)

    • Table China Hypertension Drug Production Volume by Region (2018-2023)

    • Table China Hypertension Drug Production Volume Share by Region (2018-2023)

    • Figure China Hypertension Drug Production Volume Share by Region (2018-2023)

    • Table China Hypertension Drug Production Value by Region (2018-2023)

    • Table China Hypertension Drug Production Value Share by Region (2018-2023)

    • Figure China Hypertension Drug Production Value Share by Region (2018-2023)

    • Table China Hypertension Drug Sales Volume by Region (2018-2023)

    • Table China Hypertension Drug Sales Volume Share by Region (2018-2023)

    • Figure China Hypertension Drug Sales Volume Share by Region (2018-2023)

    • Table China Hypertension Drug Sales Value by Region (2018-2023)

    • Table China Hypertension Drug Sales Value Share by Region (2018-2023)

    • Figure China Hypertension Drug Sales Value Share by Region (2018-2023)

    • Table North China Hypertension Drug Production Volume by Type (2018-2023)

    • Table North China Hypertension Drug Production Volume Share by Type (2018-2023)

    • Figure North China Hypertension Drug Production Volume Share by Type (2018-2023)

    • Table North China Hypertension Drug Sales Volume by Application (2018-2023)

    • Table North China Hypertension Drug Sales Volume Share by Application (2018-2023)

    • Figure North China Hypertension Drug Sales Volume Share by Application (2018-2023)

    • Table Central China Hypertension Drug Production Volume by Type (2018-2023)

    • Table Central China Hypertension Drug Production Volume Share by Type (2018-2023)

    • Figure Central China Hypertension Drug Production Volume Share by Type (2018-2023)

    • Table Central China Hypertension Drug Sales Volume by Application (2018-2023)

    • Table Central China Hypertension Drug Sales Volume Share by Application (2018-2023)

    • Figure Central China Hypertension Drug Sales Volume Share by Application (2018-2023)

    • Table South China Hypertension Drug Production Volume by Type (2018-2023)

    • Table South China Hypertension Drug Production Volume Share by Type (2018-2023)

    • Figure South China Hypertension Drug Production Volume Share by Type (2018-2023)

    • Table South China Hypertension Drug Sales Volume by Application (2018-2023)

    • Table South China Hypertension Drug Sales Volume Share by Application (2018-2023)

    • Figure South China Hypertension Drug Sales Volume Share by Application (2018-2023)

    • Table East China Hypertension Drug Production Volume by Type (2018-2023)

    • Table East China Hypertension Drug Production Volume Share by Type (2018-2023)

    • Figure East China Hypertension Drug Production Volume Share by Type (2018-2023)

    • Table East China Hypertension Drug Sales Volume by Application (2018-2023)

    • Table East China Hypertension Drug Sales Volume Share by Application (2018-2023)

    • Figure East China Hypertension Drug Sales Volume Share by Application (2018-2023)

    • Table Northeast China Hypertension Drug Production Volume by Type (2018-2023)

    • Table Northeast China Hypertension Drug Production Volume Share by Type (2018-2023)

    • Figure Northeast China Hypertension Drug Production Volume Share by Type (2018-2023)

    • Table Northeast China Hypertension Drug Sales Volume by Application (2018-2023)

    • Table Northeast China Hypertension Drug Sales Volume Share by Application (2018-2023)

    • Figure Northeast China Hypertension Drug Sales Volume Share by Application (2018-2023)

    • Table Southwest China Hypertension Drug Production Volume by Type (2018-2023)

    • Table Southwest China Hypertension Drug Production Volume Share by Type (2018-2023)

    • Figure Southwest China Hypertension Drug Production Volume Share by Type (2018-2023)

    • Table Southwest China Hypertension Drug Sales Volume by Application (2018-2023)

    • Table Southwest China Hypertension Drug Sales Volume Share by Application (2018-2023)

    • Figure Southwest China Hypertension Drug Sales Volume Share by Application (2018-2023)

    • Table Northwest China Hypertension Drug Production Volume by Type (2018-2023)

    • Table Northwest China Hypertension Drug Production Volume Share by Type (2018-2023)

    • Figure Northwest China Hypertension Drug Production Volume Share by Type (2018-2023)

    • Table Northwest China Hypertension Drug Sales Volume by Application (2018-2023)

    • Table Northwest China Hypertension Drug Sales Volume Share by Application (2018-2023)

    • Figure Northwest China Hypertension Drug Sales Volume Share by Application (2018-2023)

    • Table Merck & Co Company Profile

    • Table Merck & Co Hypertension Drug Revenue, Price and Gross (2018-2023)

    • Table AstraZeneca Plc Company Profile

    • Table AstraZeneca Plc Hypertension Drug Revenue, Price and Gross (2018-2023)

    • Table Pfizer Inc Company Profile

    • Table Pfizer Inc Hypertension Drug Revenue, Price and Gross (2018-2023)

    • Table Novartis AG Company Profile

    • Table Novartis AG Hypertension Drug Revenue, Price and Gross (2018-2023)

    • Table Lupin Limited Company Profile

    • Table Lupin Limited Hypertension Drug Revenue, Price and Gross (2018-2023)

    • Table Sanofi SA Company Profile

    • Table Sanofi SA Hypertension Drug Revenue, Price and Gross (2018-2023)

    • Table Boehringer Ingelheim Company Profile

    • Table Boehringer Ingelheim Hypertension Drug Revenue, Price and Gross (2018-2023)

    • Table Daiichi - Sankyo Company Profile

    • Table Daiichi - Sankyo Hypertension Drug Revenue, Price and Gross (2018-2023)

    • Table Johnson & Johnson Ltd Company Profile

    • Table Johnson & Johnson Ltd Hypertension Drug Revenue, Price and Gross (2018-2023)


Report Version Choose

Report

BUY NOW

Our Customers

Beyond grateful for the confidence and support from all partners and customers.A win-win situation is our ultimate pursuit.

Beyond Consulting, Future is Feasible

We provide more professional and intelligent market reports to complement your business decisions.

CONTACT US